TNF and rheumatoid arthritis: The current indications for anti-TNF-α include immune-mediated inflammatory diseases (IMID) such as rheumatoid arthritis, Crohn's disease, juvenile idiopathic arthritis, plaque psoriasis, ankylosing spondylitis, ulcerative colitis, and non-infectious uveitis (Table 3).